Inventor
Ru Chih C. Huang
Inventor
Baltimore, MD, US
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07CAcyclic or carbocyclic compounds11%
C07DHeterocyclic compounds4%
C07KPeptides4%
C12NMicroorganisms or enzymes4%
LOC164%
PatentTitleYear
D0916175Tripod2021D0916174Tripod2021RE046907Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with metabolic modulators20189,877,978'Compositions comprising NDGA derivatives and sorafenib and their use in treatment of cancer'20189,456,995'Methods for inhibition of BNIP3 and prevention and treatment of ischemia reperfusion injury by tetra-O-methyl nordihydroguaiaretic acid'20169,284,565'Bacterial expression plasmid'20169,259,433'Synergistic antiviral compositions comprising a viral attachment inhibitor, an integration inhibitor, and a proviral transcription inhibitor, and their use'20169,149,526'Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with metabolic modulators'20159,101,567'Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine'20159,084,779'Conjugates of nitroimidazoles and their use as chemotherapeutic agents'20159,005,889'Synergistic antiviral compositions comprising a viral attachment inhibitor, integration inhibitor, and proviral transcription inhibitor'20158,440,648'Methods and compositions for treatment of intraepithelial neoplasia'20138,420,692'Heterocyclic and carbonate derivatives of NDGA and their use as new anti-HIV and anti-cancer agents'20138,318,815'Method for treatment of tumors using nordihydroguaiaretic acid derivatives'20127,741,357'Heterocyclic and carbonate derivatives of NDGA and their use as new anti-HIV and anti-cancer agents'20107,728,036'Methods for delivery of catecholic butanes for treatment of tumors'2010RE040246'Method for the suppression of viral growth'20087,071,227'Antiviral compositions and methods of use'20066,958,411'Nordihydroguaiartic derivatives for use in treatment of tumors'20056,777,444'Method for regulation of gene expression in eukaryotic cells using nordihydroguaiaretic acid derivatives'20046,608,108'Method for treatment of tumors using nordihydroguaiaretic acid derivatives'20036,417,234'Nordihydroguaiaretic derivatives for use in treatment of tumors'20026,365,787'Compounds for the suppression of HIV TAT transactivation'20026,291,524'Method for the suppression of viral growth'20016,214,874'Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N'20015,663,209'Compounds for the suppression of HIV Tat transactivation'19975,445,954'System for automatic gene amplification and expression'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–2018Patents assigned to UNIV JOHNS HOPKINS (25)· patent assignee history
1995–2018Based in Baltimore, MD, US· patent location history
2010–2013Patents assigned to ERIMOS PHARMACEUTICALS LLC (2)· patent assignee history
2012–2016Patents assigned to HUANG RU CHIH C (7)· patent assignee history
2013–2015Patents assigned to HWU JIH RU (2)· patent assignee history
2021Patents assigned to Gong qiu (2)· patent assignee history
2021Based in Zhongshan, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV JOHNS HOPKINS | 25 | 1995–2018 |
| HUANG RU CHIH Cself | 7 | 2012–2016 |
| ERIMOS PHARMACEUTICALS LLC | 2 | 2010–2013 |
| Gong qiu | 2 | 2021 |
| HWU JIH RU | 2 | 2013–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Baltimore, Maryland, US | 25 | 1995–2018 |
| Zhongshan, CN | 2 | 2021 |